Monitoring the safety of influenza A/H1N1 pandemic and seasonal vaccines in Morocco [0.03%]
摩洛哥A型H1N1流感大流行与季节性疫苗的安全性监测
Amina Tebaa,Raja Benkirane,Loubna Alj et al.
Amina Tebaa et al.
Background: A vaccination campaign against pandemic influenza A/H1N1 was implemented in Morocco between November 2009 and April 2010. Overall, 705,883 subjects were vaccinated by Pandemrix, Arepanrix, and Panenza. The adv...
Mohammed Al-Kassim Hassan,Auwal Adam Bala,Abubakar Ibrahim Jatau
Mohammed Al-Kassim Hassan
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review [0.03%]
全球带状疱疹发病率、疾病负担及疫苗可及性：综述
Catherina X Pan,Michelle S Lee,Vinod E Nambudiri
Catherina X Pan
Herpes zoster (HZ) is a neurocutaneous disease that causes significant morbidity worldwide. The disease is caused by the reactivation of the varicella-zoster virus (VZV), which leads to the development of a painful, vesicular rash and can c...
Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19 [0.03%]
识别医护人员中的高风险亚组以优先接种新型冠状病毒疫苗
Mohsina Haq,Asif Rehman,Momina Haq et al.
Mohsina Haq et al.
Background: Health care workers (HCWs) are exposed to high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to close contact with infected patients in hospital. The objective of this stud...
Joshua E Phillipson,Ron Babecoff,Tamar Ben-Yedidia
Joshua E Phillipson
The influenza virus causes significant human morbidity and mortality annually and poses a pandemic threat. In addition, the virus frequently mutates, contributing to thousands of identified strains. Current influenza vaccine solutions are s...
COVID-19 vaccine hesitancy: Pakistan struggles to vaccinate its way out of the pandemic [0.03%]
新冠疫苗犹豫不决：巴基斯坦艰难走出疫情靠接种疫苗困难重重
Qasim Mehmood,Irfan Ullah,Mohammad Mehedi Hasan et al.
Qasim Mehmood et al.
Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance [0.03%]
佐剂重组带状疱疹疫苗的安全性和反应原性：临床试验和上市后监测的经验教训
Joseph Fiore,Maribel Miranda Co-van der Mee,Andrés Maldonado et al.
Joseph Fiore et al.
An adjuvanted recombinant zoster vaccine (RZV) is licensed for the prevention of herpes zoster. This paper reviews its safety and reactogenicity. A pooled analysis of two pivotal randomized Phase-3 trials (NCT01165177, NCT01165229) in adult...
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic [0.03%]
关于COVID-19疫苗的综合文献回顾以及SARS-CoV-2变异体在疫情中的作用
Charles Yap,Abulhassan Ali,Amogh Prabhakar et al.
Charles Yap et al.
Since the outbreak of the COVID-19 pandemic, there has been a rapid expansion in vaccine research focusing on exploiting the novel discoveries on the pathophysiology, genomics, and molecular biology of the severe acute respiratory syndrome ...
Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India [0.03%]
来自南印度一家三级诊疗医院接种COVID-19疫苗后不良反应事件：90天内临床经验总结
Chetak Kadabasal Basavaraja,Juny Sebastian,Mandyam Dhati Ravi et al.
Chetak Kadabasal Basavaraja et al.
Background: The COVID-19 vaccination program was introduced in India on 16 January 2021. The Government-issued fact sheet was the only source of information regarding Adverse Events Following Immunizations (AEFIs) for the...
Jeremy Mayfield,Sumedha Bandi,Latha Ganti et al.
Jeremy Mayfield et al.
The authors of this article report on a case of a patient who presented to the emergency department (ED) in anaphylaxis after receiving the Moderna® COVID-19 vaccine. The patient was hypoxic, with diffuse wheezing bilaterally to auscultati...